|
1）Merkel M, Loeffler B, Kluger M, et al. Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan-bound lipoprotein lipase. J Biol Chem. 2005; 280: 21553-60
|
|
|
|
2）Davies BS, Beigneux AP, Barnes RH 2nd, et al. GPIHBP1 is responsible for the entry of lipoprotein lipase into capillaries. Cell Metab. 2010; 12: 42-52
|
|
|
|
|
|
3）Miyashita Y, Shirai K, Itoh Y, et al. Low lipoprotein lipase mass in preheparin serum of type 2 diabetes mellitus patients and its recovery with insulin therapy. Diabetes Res Clin Pract. 2002; 56: 181-7
|
|
|
|
|
|
4）Kern PA, Ranganathan S, Li C, et al. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab. 2001; 280: E745-51
|
|
|
|
|
|
5）Laville M, Auboeuf D, Khalfallah Y, et al. Acute regulation by insulin of phosphatidylinositol-3-kinase, Rad, Glut 4, and lipoprotein lipase mRNA levels in human muscle. J Clin Invest. 1996; 98: 43-9
|
|
|
|
|
|
6）Yost TJ, Froyd KK, Jensen DR, et al. Change in skeletal muscle lipoprotein lipase activity in response to insulin/glucose in non-insulin-dependent diabetes mellitus. Metabolism. 1995; 44: 786-90
|
|
|
|
|
|
7）Garcia-Arcos I, Hiyama Y, Drosatos K, et al. Adipose specific lipoprotein lipase deficiency more profoundly affects brown than white fat biology. J Biol Chem. 2013; 288: 14046-58
|
|
|
|
|
|
8）Benlian P, De Gennes JL, Foubert L, et al. Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene. N Engl J Med. 1996; 335: 848-54
|
|
|
|
|
|
9）Ebara T, Okubo M, Horinishi A, et al. No evidence of accelerated atherosclerosis in a 66-yr-old chylomicronemia patient homozygous for the nonsense mutation (Tyr61-->stop) in the lipoprotein lipase gene. Atherosclerosis. 2001; 159: 375-9
|
|
|
|
|
|
10）Ebara T, Endo Y, Yoshiike S, et al. A 60-y-old chylomicronemia patient homozygous for missense mutation (G188E) in the lipoprotein lipase gene showed no accelerated atherosclerosis. Clin Chim Acta. 2007; 386: 100-4
|
|
|
|
|
|
11）Shimada M, Ishibashi S, Inaba T, et al. Suppression of diet-induced atherosclerosis in low density lipoprotein receptor knockout mice overexpressing lipoprotein lipase. Proc Natl Acad Sci U S A. 1996; 93: 7242-6
|
|
|
|
|
|
12）Yagyu H, Ishibashi S, Chen Z, et al. Overexpressed lipoprotein lipase protects against atherosclerosis in apolipoprotein E knockout mice. J Lipid Res. 1999; 40: 1677-85
|
|
|
|
|
|
13）Babaev VR, Fazio S, Gleaves LA, et al. Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in vivo. J Clin Invest. 1999; 103: 1697-705
|
|
|
|
|
|
14）Van Eck M, Zimmermann R, Groot PH, et al. Role of macrophage-derived lipoprotein lipase in lipoprotein metabolism and atherosclerosis. Arterioscler Thromb Vasc Biol. 2000; 20: E53-62
|
|
|
|
|
|
15）Takahashi M, Yagyu H, Tazoe F, et al. Macrophage lipoprotein lipase modulates the development of atherosclerosis but not adiposity. J Lipid Res. 2013; 54: 1124-34
|
|
|
|
|